BUZZ-Integra LifeSciences shares fall after lowering annual performance forecast

October 2 - ** Integra LifeSciences (IART.O) shares fell 14.6% to $13.74—marking a new low since May 11

** The medical device maker lowered (link) its FY2026 revenue forecast to $1.63 billion to $1.65 billion from its previous estimate of $1.65 billion to $1.70 billion

** Its FY2026 adjusted earnings per share (EPS) forecast was cut from $2.40–$2.50 to $2.30–$2.40

** The third quarter revenue guidance was trimmed from $410 million–$425 million to $410 million–$412 million

** The company said the flood at its Cincinnati plant in July led to a revenue reduction of about $7 million in Q3; it expects an impact of $15 million–$20 million in Q4 revenue

** Full production recovery is expected in the second quarter of 2027

** Out of 12 brokerages, 3 rate the stock as “buy” or higher, 7 as “hold”, and 2 as “sell” or lower; the median price target is $19—according to LSEG compiled data

** Including this day’s share price drop, the stock is up 10.4% year-to-date

(To assist non-English speakers, Reuters has provided automated translations of its reports into several other languages. As automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of translated text and provides it solely for reader convenience. Reuters accepts no responsibility for any damages or losses arising from use of the automated translation feature.)